| Michael Kirkland Ritchie, MD | |
|
200 Abraham Flexner Way, Louisville, KY 40202-2877 | |
| (502) 587-4011 | |
| (502) 587-4156 |
| Full Name | Michael Kirkland Ritchie |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 200 Abraham Flexner Way, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689802480 | NPI | - | NPPES |
| 1689802480 | Medicaid | NC | |
| 7100659900 | Medicaid | KY | |
| NCL827B | Other | NC | MEDICARE |
| 189WE | Other | NC | BCBS OF NC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Area Medical Center Inc | 3375441637 | 675 |
News Archive
Research using a newly developed algorithm has significantly advanced understanding of the molecular events associated with the most common primary brain tumor in adults, human glioblastoma (GBM).
Japanese research group led by Professor Junichi Nabekura in National Institute for Physiological Sciences, NIPS, Japan, found that, after cerebral stroke in one side of the mouse brain, another side of the brain rewires its neural circuits to recuperate from damaged neural function. The Japan Science and Technology Agency (JST) supported this study. They report their finding in Journal of Neuroscience, on August 12, 2009.
Dr. David Blumenthal, HHS' National Coordinator for Health Information Technology, today announced the launch of Health IT Buzz, a new blog that will allow readers to learn more about health information technology (health IT) and provide a space for consumers, providers, policymakers, and technology experts to share their ideas and concerns regarding health IT.
Diabetes is currently treated using incretin hormones to reduce the risk of cardiovascular disease and other medical issues that the illness can trigger.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
› Verified 5 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
Research using a newly developed algorithm has significantly advanced understanding of the molecular events associated with the most common primary brain tumor in adults, human glioblastoma (GBM).
Japanese research group led by Professor Junichi Nabekura in National Institute for Physiological Sciences, NIPS, Japan, found that, after cerebral stroke in one side of the mouse brain, another side of the brain rewires its neural circuits to recuperate from damaged neural function. The Japan Science and Technology Agency (JST) supported this study. They report their finding in Journal of Neuroscience, on August 12, 2009.
Dr. David Blumenthal, HHS' National Coordinator for Health Information Technology, today announced the launch of Health IT Buzz, a new blog that will allow readers to learn more about health information technology (health IT) and provide a space for consumers, providers, policymakers, and technology experts to share their ideas and concerns regarding health IT.
Diabetes is currently treated using incretin hormones to reduce the risk of cardiovascular disease and other medical issues that the illness can trigger.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Kirkland Ritchie, MD Po Box 909, Louisville, KY 40201-0909 Ph: () - | Michael Kirkland Ritchie, MD 200 Abraham Flexner Way, Louisville, KY 40202-2877 Ph: (502) 587-4011 |
News Archive
Research using a newly developed algorithm has significantly advanced understanding of the molecular events associated with the most common primary brain tumor in adults, human glioblastoma (GBM).
Japanese research group led by Professor Junichi Nabekura in National Institute for Physiological Sciences, NIPS, Japan, found that, after cerebral stroke in one side of the mouse brain, another side of the brain rewires its neural circuits to recuperate from damaged neural function. The Japan Science and Technology Agency (JST) supported this study. They report their finding in Journal of Neuroscience, on August 12, 2009.
Dr. David Blumenthal, HHS' National Coordinator for Health Information Technology, today announced the launch of Health IT Buzz, a new blog that will allow readers to learn more about health information technology (health IT) and provide a space for consumers, providers, policymakers, and technology experts to share their ideas and concerns regarding health IT.
Diabetes is currently treated using incretin hormones to reduce the risk of cardiovascular disease and other medical issues that the illness can trigger.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
› Verified 5 days ago
Cindy J Code, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3950 Kresge Way, Suite 303, Louisville, KY 40207 Phone: 502-896-1880 Fax: 502-896-1887 | |
Dr. Uchenna Loretta Ozor, M.D Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 E Chestnut St Bldg Suite303, Louisville, KY 40202 Phone: 502-629-5552 Fax: 502-629-3132 | |
Mohamed Hegazi, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 529 S Jackson St, Louisville, KY 40202 Phone: 502-562-4270 | |
Dr. Michael Patrick Krease, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1169 Eastern Pkwy Ste G58, Louisville, KY 40217 Phone: 502-452-9567 | |
Dr. Ramsey Nasri Nassar, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6400 Dutchmans Pkwy, Ste 250, Louisville, KY 40205 Phone: 502-587-9660 Fax: 502-540-5615 | |
Jeanne M Thompson, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Audubon Plaza Dr, Ll2, Louisville, KY 40217 Phone: 502-636-8095 Fax: 502-636-8097 | |
Terrence P Donohue, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3101 Poplar Level Rd Ste 101, Louisville, KY 40213 Phone: 502-636-7444 Fax: 502-636-7112 |